Clinical & translational oncology

• 

  Año 2022, Vol. 24, Número 2. Texto Completo Ejemplar

  • Review Article

    • Cyclin‑dependent kinase (CDK) inhibitors in solid tumors: a review of clinical trials

      E. Panagiotou, G. Gomatou, I. P. Trontzas, N. Syrigos, E. Kotteas

      • Resumen
      • Texto completo

      págs. 161-192

      

    • Microbiota and cancer:: current understanding and mechanistic implications

      S. A. Khan, A.T. Sirsat, H. Singh, P. Cash

      • Resumen
      • Texto completo

      págs. 193-202

      

    • Biological functions and potential therapeutic applications of huntingtin‑associated protein 1:: progress and prospects

      X. Zhao, A. Chen, Z. Wang, Xiao Han Xu, Y. Tao

      • Resumen
      • Texto completo

      págs. 203-214

      

  • Special Article

    • SEOR SBRT‑SG stereotactic body radiation therapy consensus guidelines for non‑spine bone metastasis

      F. López Campos, Jon Cacicedo Fernández de Bobadilla, Felipe Couñago Lorenzo, María Rosario García Campelo, Olwen Leaman, Arturo Navarro Martín, Héctor Pérez Montero, Antonio José Conde Moreno

      • Resumen
      • Texto completo

      págs. 215-226

      

    • Multidisciplinary consensus on the criteria for fertility preservation in cancer patients

      Ana Santaballa Bertrán, Catalina Márquez-Vega, Álvaro Rodríguez Lescure, Angeles Rovirosa Casino, María Luisa Vázquez de la Torre, Izaskun Ceberio Etxetxipia, M. Andrés, L. Bassas, E. Ceballos Garcia, Francisco Javier Domingo del Pozo, Dolors Manau Trullàs

      • Resumen
      • Texto completo

      págs. 227-243

      

  • Research Article

    • Del‑1 enhances therapeutic efficacy of bacterial cancer immunotherapy by blocking recruitment of tumor‑infiltrating neutrophils

      S. Tian, G. Lin, L. Piao, X. Liu

      • Resumen
      • Texto completo

      págs. 244-253

      

    • Exclusive 3D‑brachytherapy as a good option for stage‑I inoperable endometrial cancer: a retrospective analysis in the gynaecological cancer GEC‑ESTRO Working Group

      Angeles Rovirosa Casino, Yaowen Zhang, Cyrus Chargari, Rachel Cooper, Peter Bownes, Piotr Wojcieszek, Magdalena Stankiewicz, Peter Hoskin, Elzbieta Van der Steen Banasik, Barbara Segedin, Dina Najjari, Richard Pötter, Kari Tanderup, Erik Van Limbergen

      • Resumen
      • Texto completo

      págs. 254-265

      

    • MicroRNA‑802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway

      L.F. Gao, S. Jia, Q. M. Zhang, Y.F. Xia, C.J. Li, Y.H. Li

      • Resumen
      • Texto completo

      págs. 266-275

      

    • Long‑term outcomes of spinal SBRT. Is it important to select the treatment time?

      Héctor Pérez Montero, J. Godino, A. Lozano, L. Asiáin, I. Martínez Romera, José Javier Sánchez Hernández, R. de BlasFernández, E. Fernandez, M. Stefanovic, M. Stefanovic, N. García, J. Martínez, F. Guedea, Arturo Navarro Martín

      • Resumen
      • Texto completo

      págs. 276-287

      

    • Exosome‑mediated delivery of SCD‑1 siRNA promoted the death of anaplastic thyroid carcinoma cells via regulating ROS level

      M.H. Wang, Y. Ye, M. Zhang, B.R. Zhou, J.N. Wang, Y.N. Song, W. Xia

      • Resumen
      • Texto completo

      págs. 288-296

      

    • Thrombospondin‑2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

      J. Byrling, K.S. Hilmersson, D. Ansari, R. Andersson, Bernt Andersson

      • Resumen
      • Texto completo

      págs. 297-304

      

    • The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse

      J. Ren, B. Guo, H. Sui, J. Chen, L. Zhang, C. Lv, B. Li

      • Resumen
      • Texto completo

      págs. 305-318

      

    • Exploratory analysis of clinical benefit of ipilimumab and nivolumab treatment in patients with metastatic melanoma from a single institution

      C.M. Vila, F.A. Moreno, Maitane Múgica Estébanez, G.R. Ares, G. Villacampa, P. Dashti, H.S. Oberoi, Rafael Martínez Huertas, Pedro Jares, L. Alós , C. Teixido, A.R. Rull Ortuño, Marcelo Sánchez, Josep Malvehy, Esther Carcelero San Martín, Izaskun Valduvieco Ruiz, A. Fernández

      • Resumen
      • Texto completo

      págs. 319-330

      

    • The peri‑ and intratumoral immune cell infiltrate and PD‑L1 status in invasive squamous cell carcinomas of the penis

      T. Muller, M. Demes, A. Lehn, J. Köllermann, S. Vallo, P. J. Wild, R. Winkelmann

      • Resumen
      • Texto completo

      págs. 331-341

      

    • Stereotactic body radiotherapy for early‑stage non‑small cell lung cancer:: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

      Pilar Samper Ots, Carmen Vallejo Ocaña, Margarita Martín Martín, Francisco Javier Celada Álvarez, D. Farga Albiol, Piedad Almendros Blanco, Ana Hernández Machancoses, Mikel Rico Osés, S. Flamarique, Fabiola Romero Ruperto, C. Bueno, Enrique Amaya, L.L. Guerrero Gómez, Felipe Couñago Lorenzo, Pino Alcántara Carrió, J. C. Ruiz, José Luis Monroy Antón, P. Saez Bueno, Javier Luna Tirado, Mª del Mar Puertas, Assyatou Bobo Sow, I. Diaz de Cerio Martínez, N. Gascón Costoso, Carlos Ferrer Albiach

      • Resumen
      • Texto completo

      págs. 342-349

      

    • Future care for long‑term cancer survivors:: towards a new model

      Mariano Provencio Pulla, Nuria Romero Laorden, Josep Tabernero Caturla, Ruth Vera García, D.V. Baz, A. Arraiza, Carlos Camps Herrero, Enriqueta Felip Font, María Pilar Garrido López, B. Gaspar, Antonio Llombart Cussac, A. López González, I. Magallón Pedrera, I. Ibáñez de Cáceres, J.M. Olmos, Encarna Mur, Andrés Navarro Ruiz, Aida Pastor del Campo, Inmaculada Peiró Martínez, Eduardo Polo Marqués, Álvaro Rodríguez Lescure

      • Resumen
      • Texto completo

      págs. 350-362

      

    • MiR‑493‑5p inhibits the malignant development of gliomas via suppressing E2F3‑mediated dysfunctions of P53 and PI3K/AKT pathways

      Hong Liu, Zhen Li, Hu Sun

      • Resumen
      • Texto completo

      págs. 363-370

      

    • Benefits of early salvage therapy on oncological outcomes in high‑risk prostate cancer with persistent PSA after radical prostatectom

      D. Milonas, A. Laenen, Z. Venclovas, L. Jarusevicius, G. Devos, S. Joniau

      • Resumen
      • Texto completo

      págs. 371-378

      

    • Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non‑small‑cell lung cancer

      D. Geng, Q. Guo, S. Huang, H. Zhang, S. Guo, X. Li

      • Resumen
      • Texto completo

      págs. 379-387

      

  • Brief Research Article

    • Post‑hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy: a dreadful enemy

      Laura Murillo Sanjuán, Judith Balmaña, Alba de Pablo García-Cuenca, J. Lorente, L.M. Larocca, Eva Carrasco, C. Díaz de Heredia Rubio

      • Resumen
      • Texto completo

      págs. 388-392